<DOC>
	<DOCNO>NCT01067625</DOCNO>
	<brief_summary>This study prospective single-arm , multicenter study evaluate safety effectiveness TOGA® Procedure treatment morbid obesity .</brief_summary>
	<brief_title>Endoscopic Bariatric Stapling Pilot Study</brief_title>
	<detailed_description />
	<criteria>1 . Age 18 year 60 year 2 . Eligible bariatric surgery per US National Institute Health ( NIH ) guideline BMI ≥ 40 kg/m2 &lt; 55 kg/m2 , BMI ≥ 35 kg/m2 one comorbidities . Comorbidities define diabetes , pulmonary disease , cardiac disease , hypertension [ systolic blood pressure ≥140 mm Hg diastolic blood pressure ≥ 90 mm Hg ( ) treatment hypertension ] 3 . History obesity least 2.5 year 4 . History failure nonsurgical weight loss method . 5 . Agree comply substantial dietary restriction require procedure . 6 . Understands risks procedure , agree follow protocol requirement , include signing informed consent , return followup visit complete required testing , complete diet behavior modification counseling . 1 . Patient history inflammatory disease gastrointestinal tract include Crohn 's disease ulcerative colitis . 2 . Significant known esophageal disease include grade 34 esophagitis , stricture , Barrett 's esophagus , esophageal cancer , esophageal diverticulum , nutcracker esophagus , achalasia , esophageal dysmotility . 3 . Severe coagulopathy , upper GI bleeding condition esophageal gastric varix , congenital acquire telangiectasia . 4 . Congenital acquire anomaly GI tract atresia stenosis . 5 . Hiatal hernia ≥2cm 6 . Severe cardiopulmonary disease serious organic disease include HIV cancer . 7 . Currently pregnant nursing . Potentially childbearing ( i.e postmenopausal surgically sterilize ) willing use effective method contraception next 12 month . 8 . Current alcohol drug addiction . 9 . Mentally retarded emotionally unstable , exhibit psychological characteristic , opinion investigator psychologist/psychiatrist , make subject poor candidate procedure . 10 . Previous gastric , esophageal , pancreatic , bariatric surgery . 11 . Infection anywhere body time procedure . 12 . Patient history scleroderma . 13 . Thyroid disease control medication . 14 . Participating another ongoing clinical trial concomitant diagnosis therapeutic intervention would adversely affect integrity clinical trial . 15 . Known active Hpylori infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>